
GRDN Stock Forecast & Price Target
GRDN Analyst Ratings
Bulls say
Guardian Pharmacy Service is well positioned in the long-term care market and has a promising growth potential as the industry consolidates. Additionally, the company has reliable sources of revenue from its pharmaceutical and medical products sales, along with a strong track record in acquisitions and a clean balance sheet. With a growing focus on optimizing operations, increasing MedicarePart D mix, and improving margins, Guardian Pharmacy Service has a positive outlook for future profitability, further supported by its strong financial flexibility and leading technology assets.
Bears say
Guardian Pharmacy Service is facing margin pressure due to its ongoing expansion activity and recent acquisitions. While the company's technology capabilities provide a competitive advantage, it remains to be seen if these expansions will result in meaningful earnings in the near future, as facilities typically take up to 4 years to reach full potential. However, the company's strong financial flexibility and robust pipeline of potential acquisitions suggest continued growth in the long-term.
This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.
GRDN Analyst Forecast & Price Prediction
Start investing in GRDN
Order type
Buy in
Order amount
Est. shares
0 shares